SCHEMBL26568779

SCHEMBL26568779

O=C(O)CNC(=O)c1cccc(-c2ccccc2)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.74
KDM4E B2RXH2 1/20 0.74
ALDH1A1 P00352 1/20 0.74
SMN1; SMN2 Q16637 1/20 0.74
HDAC8 Q9BY41 1/20 0.64
NR1H4 Q96RI1 2/20 0.61
EPHX2 P34913 1/20 0.61
MAPK1 P28482 1/20 0.57
CFD P00746 1/20 0.56
PTPRC P08575 2/20 0.55
CTSL P07711 1/20 0.55
PTPN13 Q12923 1/20 0.55
KMO O15229 1/20 0.55
ERCC5 P28715 1/20 0.54
FEN1 P39748 1/20 0.54
HDAC1 Q13547 2/20 0.53
HDAC6 Q9UBN7 1/20 0.53
EGLN1 Q9GZT9 1/20 0.52
CDK4 P11802 1/20 0.52
CCND1 P24385 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26119946 0.89 HPGD (0.69) HPGDKDM4EALDH1A1SMN1; SMN2HDAC8
SCHEMBL26114243 0.89 HPGD (0.73) HPGDKDM4EALDH1A1SMN1; SMN2HDAC8
SCHEMBL1840451 0.87 KDM4E (0.60) HPGDKDM4EALDH1A1SMN1; SMN2HDAC8
SCHEMBL26568778 0.84 MAPK1 (0.80) HPGDKDM4EALDH1A1SMN1; SMN2HDAC8
SCHEMBL71847 0.84 KDM4E (0.65) HPGDKDM4EALDH1A1SMN1; SMN2HDAC8
SCHEMBL11675554 0.83 PPARG (0.62) HPGDKDM4EALDH1A1SMN1; SMN2HDAC8
Hippuric Acid SCHEMBL428479 0.83 GAA (0.68) KDM4ESMN1; SMN2HDAC8EPHX2PTPRC
SCHEMBL22030672 0.83 GAA (0.68) KDM4ESMN1; SMN2HDAC8EPHX2PTPRC
Hippuric Acid SCHEMBL7486 0.83 GAA (0.68) KDM4ESMN1; SMN2HDAC8EPHX2PTPRC
SCHEMBL18376133 0.83 CFD (0.64) HPGDKDM4EALDH1A1SMN1; SMN2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023183405-A2 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS ALEXION PHARMACEUTICALS, INC. (US) 2023-09-28 WO disclosed